 |
PDBsum entry 5e0u
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
DNA binding protein
|
PDB id
|
|
|
|
5e0u
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
DNA binding protein
|
 |
|
Title:
|
 |
Human pcna variant (s228i) complexed with p21 at 1.9 angstroms
|
|
Structure:
|
 |
Proliferating cell nuclear antigen. Chain: a, b, c. Synonym: pcna,cyclin. Engineered: yes. Mutation: yes. Cyclin-dependent kinase inhibitor 1. Chain: d, e, f. Synonym: cdk-interacting protein 1,melanoma differentiation- associated protein 6,mda-6,p21.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: pcna. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Organism_taxid: 9606
|
|
Resolution:
|
 |
|
1.93Å
|
R-factor:
|
0.170
|
R-free:
|
0.221
|
|
|
Authors:
|
 |
C.M.Duffy,B.J.Hilbert,B.A.Kelch
|
|
Key ref:
|
 |
C.M.Duffy
et al.
(2016).
A Disease-Causing Variant in PCNA Disrupts a Promiscuous Protein Binding Site.
J Mol Biol,
428,
1023-1040.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
29-Sep-15
|
Release date:
|
20-Apr-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P12004
(PCNA_HUMAN) -
Proliferating cell nuclear antigen from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
261 a.a.
255 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D, E, F:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
428:1023-1040
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
A Disease-Causing Variant in PCNA Disrupts a Promiscuous Protein Binding Site.
|
|
C.M.Duffy,
B.J.Hilbert,
B.A.Kelch.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The eukaryotic DNA polymerase sliding clamp, proliferating cell nuclear antigen
or PCNA, is a ring-shaped protein complex that surrounds DNA to act as a sliding
platform for increasing processivity of cellular replicases and for coordinating
various cellular pathways with DNA replication. A single point mutation,
Ser228Ile, in the human PCNA gene was recently identified to cause a disease
whose symptoms resemble those of DNA damage and repair disorders. The mutation
lies near the binding site for most PCNA-interacting proteins. However, the
structural consequences of the S228I mutation are unknown. Here, we describe the
structure of the disease-causing variant, which reveals a large conformational
change that dramatically transforms the binding pocket for PCNA client proteins.
We show that the mutation markedly alters the binding energetics for some client
proteins, while another, p21(CIP1), is only mildly affected. Structures of the
disease variant bound to peptides derived from two PCNA partner proteins reveal
that the binding pocket can adjust conformation to accommodate some ligands,
indicating that the binding site is dynamic and pliable. Our work has
implications for the plasticity of the binding site in PCNA and reveals how a
disease mutation selectively alters interactions to a promiscuous binding site
that is critical for DNA metabolism.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
| |